print
DoseCheck 5-FU PCM Assay for pharmacokinetic-guided dose management of cancer chemotherapy
- Source agency:
- NHSC
- Date of Submission:
- 01/04/2010
- Date of Printing:
- 05/02/2012
- Technology name:
- DoseCheck 5-FU Personalised Chemotherapy Management (PCM) Assay
- Technology - type(s):
- Other, not otherwise specified, Diagnostics
- Patient indications:
- Cancer patients receiving chemotherapy in which 5-FU is administered by continuous infusion.